Copyright Reports & Markets. All rights reserved.

Covid-19 Impact on Surgical Anti-Adhesion Market, Global Research Reports 2020-2021

Request for Sample of this report
Buy now
  • 1.1 Research Scope
  • 1.2 Market Segmentation
  • 1.3 Research Objectives
  • 1.4 Research Methodology
    • 1.4.1 Research Process
    • 1.4.2 Data Triangulation
    • 1.4.3 Research Approach
    • 1.4.4 Base Year
  • 1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
    • 1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
    • 1.5.2 Covid-19 Impact: Commodity Prices Indices
    • 1.5.3 Covid-19 Impact: Global Major Government Policy
  • 1.6 The Covid-19 Impact on Surgical Anti-Adhesion Industry
  • 1.7 COVID-19 Impact: Surgical Anti-Adhesion Market Trends

    • 2 Global Surgical Anti-Adhesion Quarterly Market Size Analysis

    • 2.1 Surgical Anti-Adhesion Business Impact Assessment - COVID-19
      • 2.1.1 Global Surgical Anti-Adhesion Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
      • 2.1.2 Global Surgical Anti-Adhesion Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
    • 2.2 Global Surgical Anti-Adhesion Quarterly Market Size 2020-2021
    • 2.3 COVID-19-Driven Market Dynamics and Factor Analysis
      • 2.3.1 Drivers
      • 2.3.2 Restraints
      • 2.3.3 Opportunities
      • 2.3.4 Challenges

    3 Quarterly Competitive Assessment, 2020

    • 3.1 Global Surgical Anti-Adhesion Quarterly Market Size by Manufacturers, 2019 VS 2020
    • 3.2 Global Surgical Anti-Adhesion Factory Price by Manufacturers
    • 3.3 Location of Key Manufacturers Surgical Anti-Adhesion Manufacturing Factories and Area Served
    • 3.4 Date of Key Manufacturers Enter into Surgical Anti-Adhesion Market
    • 3.5 Key Manufacturers Surgical Anti-Adhesion Product Offered
    • 3.6 Mergers & Acquisitions, Expansion Plans

    4 Impact of Covid-19 on Surgical Anti-Adhesion Segments, By Type

    • 4.1 Introduction
      • 1.4.1 Gels
      • 1.4.2 Films
    • 4.2 By Type, Global Surgical Anti-Adhesion Market Size, 2019-2021
      • 4.2.1 By Type, Global Surgical Anti-Adhesion Market Size by Type, 2020-2021
      • 4.2.2 By Type, Global Surgical Anti-Adhesion Price, 2020-2021

    5 Impact of Covid-19 on Surgical Anti-Adhesion Segments, By Application

    • 5.1 Overview
      • 5.5.1 General/abdominal Surgery
      • 5.5.2 Pelvic/gynecological Surgery
      • 5.5.3 Other Surgery
    • 5.2 By Application, Global Surgical Anti-Adhesion Market Size, 2019-2021
      • 5.2.1 By Application, Global Surgical Anti-Adhesion Market Size by Application, 2019-2021
      • 5.2.2 By Application, Global Surgical Anti-Adhesion Price, 2020-2021

    6 Geographic Analysis

    • 6.1 Introduction
    • 6.2 North America
      • 6.2.1 Macroeconomic Indicators of US
      • 6.2.2 US
      • 6.2.3 Canada
    • 6.3 Europe
      • 6.3.1 Macroeconomic Indicators of Europe
      • 6.3.2 Germany
      • 6.3.3 France
      • 6.3.4 UK
      • 6.3.5 Italy
    • 6.4 Asia-Pacific
      • 6.4.1 Macroeconomic Indicators of Asia-Pacific
      • 6.4.2 China
      • 6.4.3 Japan
      • 6.4.4 South Korea
      • 6.4.5 India
      • 6.4.6 ASEAN
    • 6.5 Rest of World
      • 6.5.1 Latin America
      • 6.5.2 Middle East and Africa

    7 Company Profiles

    • 7.1 Ethicon
      • 7.1.1 Ethicon Business Overview
      • 7.1.2 Ethicon Surgical Anti-Adhesion Quarterly Production and Revenue, 2020
      • 7.1.3 Ethicon Surgical Anti-Adhesion Product Introduction
      • 7.1.4 Ethicon Response to COVID-19 and Related Developments
    • 7.2 SANOFI
      • 7.2.1 SANOFI Business Overview
      • 7.2.2 SANOFI Surgical Anti-Adhesion Quarterly Production and Revenue, 2020
      • 7.2.3 SANOFI Surgical Anti-Adhesion Product Introduction
      • 7.2.4 SANOFI Response to COVID-19 and Related Developments
    • 7.3 Baxter International
      • 7.3.1 Baxter International Business Overview
      • 7.3.2 Baxter International Surgical Anti-Adhesion Quarterly Production and Revenue, 2020
      • 7.3.3 Baxter International Surgical Anti-Adhesion Product Introduction
      • 7.3.4 Baxter International Response to COVID-19 and Related Developments
    • 7.4 Pathfinder Cell Therapy
      • 7.4.1 Pathfinder Cell Therapy Business Overview
      • 7.4.2 Pathfinder Cell Therapy Surgical Anti-Adhesion Quarterly Production and Revenue, 2020
      • 7.4.3 Pathfinder Cell Therapy Surgical Anti-Adhesion Product Introduction
      • 7.4.4 Pathfinder Cell Therapy Response to COVID-19 and Related Developments
    • 7.5 Medtronic
      • 7.5.1 Medtronic Business Overview
      • 7.5.2 Medtronic Surgical Anti-Adhesion Quarterly Production and Revenue, 2020
      • 7.5.3 Medtronic Surgical Anti-Adhesion Product Introduction
      • 7.5.4 Medtronic Response to COVID-19 and Related Developments
    • 7.6 Integra Life Sciences
      • 7.6.1 Integra Life Sciences Business Overview
      • 7.6.2 Integra Life Sciences Surgical Anti-Adhesion Quarterly Production and Revenue, 2020
      • 7.6.3 Integra Life Sciences Surgical Anti-Adhesion Product Introduction
      • 7.6.4 Integra Life Sciences Response to COVID-19 and Related Developments
    • 7.7 FzioMed
      • 7.7.1 FzioMed Business Overview
      • 7.7.2 FzioMed Surgical Anti-Adhesion Quarterly Production and Revenue, 2020
      • 7.7.3 FzioMed Surgical Anti-Adhesion Product Introduction
      • 7.7.4 FzioMed Response to COVID-19 and Related Developments
    • 7.8 Anika Therapeutics
      • 7.8.1 Anika Therapeutics Business Overview
      • 7.8.2 Anika Therapeutics Surgical Anti-Adhesion Quarterly Production and Revenue, 2020
      • 7.8.3 Anika Therapeutics Surgical Anti-Adhesion Product Introduction
      • 7.8.4 Anika Therapeutics Response to COVID-19 and Related Developments
    • 7.9 Bioscompass
      • 7.9.1 Bioscompass Business Overview
      • 7.9.2 Bioscompass Surgical Anti-Adhesion Quarterly Production and Revenue, 2020
      • 7.9.3 Bioscompass Surgical Anti-Adhesion Product Introduction
      • 7.9.4 Bioscompass Response to COVID-19 and Related Developments
    • 7.10 Shanghai Haohai
      • 7.10.1 Shanghai Haohai Business Overview
      • 7.10.2 Shanghai Haohai Surgical Anti-Adhesion Quarterly Production and Revenue, 2020
      • 7.10.3 Shanghai Haohai Surgical Anti-Adhesion Product Introduction
      • 7.10.4 Shanghai Haohai Response to COVID-19 and Related Developments
    • 7.11 SJZ Yishengtang
      • 7.11.1 SJZ Yishengtang Business Overview
      • 7.11.2 SJZ Yishengtang Surgical Anti-Adhesion Quarterly Production and Revenue, 2020
      • 7.11.3 SJZ Yishengtang Surgical Anti-Adhesion Product Introduction
      • 7.11.4 SJZ Yishengtang Response to COVID-19 and Related Developments
    • 7.12 Singclean Medical
      • 7.12.1 Singclean Medical Business Overview
      • 7.12.2 Singclean Medical Surgical Anti-Adhesion Quarterly Production and Revenue, 2020
      • 7.12.3 Singclean Medical Surgical Anti-Adhesion Product Introduction
      • 7.12.4 Singclean Medical Response to COVID-19 and Related Developments
    • 7.13 SJZ Ruinuo
      • 7.13.1 SJZ Ruinuo Business Overview
      • 7.13.2 SJZ Ruinuo Surgical Anti-Adhesion Quarterly Production and Revenue, 2020
      • 7.13.3 SJZ Ruinuo Surgical Anti-Adhesion Product Introduction
      • 7.13.4 SJZ Ruinuo Response to COVID-19 and Related Developments
    • 7.14 HK Wellife
      • 7.14.1 HK Wellife Business Overview
      • 7.14.2 HK Wellife Surgical Anti-Adhesion Quarterly Production and Revenue, 2020
      • 7.14.3 HK Wellife Surgical Anti-Adhesion Product Introduction
      • 7.14.4 HK Wellife Response to COVID-19 and Related Developments

    8 Supply Chain and Sales Channels Analysis

    • 8.1 Surgical Anti-Adhesion Supply Chain Analysis
      • 8.1.1 Surgical Anti-Adhesion Supply Chain Analysis
      • 8.1.2 Covid-19 Impact on Surgical Anti-Adhesion Supply Chain
    • 8.2 Distribution Channels Analysis
      • 8.2.1 Surgical Anti-Adhesion Distribution Channels
      • 8.2.2 Covid-19 Impact on Surgical Anti-Adhesion Distribution Channels
      • 8.2.3 Surgical Anti-Adhesion Distributors
    • 8.3 Surgical Anti-Adhesion Customers

    9 Key Findings

      10 Appendix

      • 10.1 About Us

      This report covers market size and forecasts of Surgical Anti-Adhesion, including the following market information:
      Global Surgical Anti-Adhesion Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
      Global Surgical Anti-Adhesion Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
      Global Surgical Anti-Adhesion Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
      Global Surgical Anti-Adhesion Market Size by Company, 2019- 2020 (quarterly data), (US$ Million) & (K Units)

      Key market players
      Major competitors identified in this market include Ethicon, SANOFI, Baxter International, Pathfinder Cell Therapy, Medtronic, Integra Life Sciences, FzioMed, Anika Therapeutics, Bioscompass, Shanghai Haohai, SJZ Yishengtang, Singclean Medical, SJZ Ruinuo, HK Wellife, etc.

      Based on the Region:
      Asia-Pacific (China, Japan, South Korea, India and ASEAN)
      North America (US and Canada)
      Europe (Germany, France, UK and Italy)
      Rest of World (Latin America, Middle East & Africa)

      Based on the Type:
      Gels
      Films

      Based on the Application:
      General/abdominal Surgery
      Pelvic/gynecological Surgery
      Other Surgery

      Buy now